Bleeding events in lusutrombopag‐treated thrombocytopenic patients

Patients with advanced chronic liver disease are characterised by the presence of thrombocytopenia in a proportion ranging from 15% to 84%, depending on the threshold used to define this abnormality and the degree of severity of liver disease.1-3 In these patients, thrombocytopenia is multifactorial and may be associated with an increased risk of bleeding following invasive procedures.4, 5 Indeed, although the platelet count threshold associated...